Asahi Kasei Pharma Corp. Company Profile
Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. www.akpamerica.com
News Articles
Asahi Kasei Pharma Eyes Global Expansion Of Diagnostics Business
Japan's Asahi Kasei Pharma plans an expansion of its diagnostics business by developing new products and selling its blood-sugar reagents in India and the U.S.
Asahi Kasei, Teijin Seek New Delivery Methods For Osteo Drugs
At least two Japanese drug makers, Asahi Kasei and Teijin, are focusing on new ways to deliver osteoporosis drugs, one using skin patches, the other a gelatin.
Asahi Kasei aims for global market through Phase III trials with novel anticoagulant
The diversified Japanese materials group Asahi Kasei is planning to take its recombinant human thrombomodulin-alfa product ART-123 into the global arena through the start of an international Phase III...
Hisamitsu Agrees On Joint Sales With Asahi Kasei For Overactive Bladder Drug
Hisamitsu Pharmaceuticals signed a joint sales agreement with Asahi Kasei Pharmaceuticals for HOB-294 (oxybutynin) for overactive bladder treatment, the company announced Dec. 10.
Asahi Kasei Pharma, Hisamitsu sales and marketing update
ZOLL Medical announces new Tokyo-based subsidiary
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions and a wholly owned U.S. subsidiary of Asahi Kasei, has established Asahi Kasei ZOLL Medical Corporation (AZM)...
Asahi Kasei Pharma America Initiates Phase 3 Clinical Trial for ART-123 in Severe Sepsis ...
[ThermoGenesis] sells the {CryoSeal} sealant system to [Asahi Kasei Medical]
Capping off a successful relationship that has lasted over a decade, [ThermoGenesis Corp.] has sold its {CryoSeal} fibrin sealant system for wound care to [Asahi Kasei Medical Co. Ltd.], the transfusi...
Drugs and Medications
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
PubMed Articles
The birth of the lithium-ion battery.
The moment of truth: The lithium-ion battery is currently the predominant power source for mobile phones, laptop computers, and many other portable electronic devices, and is being used increasingly i...
Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, After Subarachnoid Hemorrhage.
We investigated the anti-vasospastic potential of fasudil's active metabolite, hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage (SAH) and also its effect on hemorheological abnorm...
Case of splenogonadal fusion in an adult.
The chemical states of organic semiconductors were investigated by total-electron-yield soft X-ray absorption spectroscopy (TEY-XAS) and first-principles calculations. The organic semiconductors, pent...
Self-assembly process of Peptide amphiphile worm-like micelles.
Peptide amphiphile molecules (PA) are remarkably versatile and useful as building blocks for construction of complex supramolecular structures in a bottom-up fashion. Worm-like micelles of PA have bee...
Clinical Trials
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
The main purpose of this longitudinal study is to point out the effect of VitabranE on the ESA resistance and on the anemia observed in HD patients undergoing EPO maintenance therapy. As...
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Companies
Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care...
Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care...
Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...
Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant)...
Rakuto Kasei(Israel) Ltd. was established in 1990 as a joint venture with Rakuto Kasei Industrial Co. Japan, a leading worldwide producer of enzymes. Based on over 20 years of experience in the field...
More Information about "Asahi Kasei Pharma Corp." on BioPortfolio
We have published hundreds of Asahi Kasei Pharma Corp. news stories on BioPortfolio along with dozens of Asahi Kasei Pharma Corp. Clinical Trials and PubMed Articles about Asahi Kasei Pharma Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asahi Kasei Pharma Corp. Companies in our database. You can also find out about relevant Asahi Kasei Pharma Corp. Drugs and Medications on this site too.
